About Bioscan Research
Bioscan Research is a company based in Ahmedabad (India) founded in 2013 by Anupam Lavania and Shilpa Malik. Bioscan Research has raised $1.03 million across 5 funding rounds from investors including Indian Institute of Technology Kanpur, Bind 4.0 and iCreate. Bioscan Research offers products and services including CEREBO. Bioscan Research operates in a competitive market with competitors including ClearMind Biomedical and InfraScan, among others.
- Headquarter Ahmedabad, India
- Founders Anupam Lavania, Shilpa Malik
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioscan Research Private Limited
- Date of Incorporation 13 Sep, 2017
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$171.21 K (USD)145.43as on Mar 31, 2023
-
Net Profit
$22.34 K (USD)163.1as on Mar 31, 2023
-
EBITDA
$46.4 K (USD)220.76as on Mar 31, 2023
-
Total Equity Funding
$1.03 M (USD)
in 5 rounds
-
Latest Funding Round
$1 M (USD), Seed
Jul 22, 2026
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioscan Research
Bioscan Research offers a comprehensive portfolio of products and services, including CEREBO.
Portable tool for non-invasive detection of intracranial hemorrhage in emergencies.
Funding Insights of Bioscan Research
Bioscan Research has successfully raised a total of $1.03M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bioscan Research
Bioscan Research has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Indian Institute of Technology Kanpur, Bind 4.0 and iCreate.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government-backed accelerator program is provided for startups in Spain.
|
Locked | Locked | Locked | |
|
Startups in diverse technologies are incubated over two years.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in applied generative AI
|
Locked | Locked | Locked |
Investor details for Bioscan Research
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioscan Research
Investment portfolio details for Bioscan Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioscan Research
Detailed financials for Bioscan Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioscan Research Comparisons
Peer comparison for Bioscan Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioscan Research
Bioscan Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ClearMind Biomedical and InfraScan, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Minimally invasive surgical devices for brain hemorrhage are developed.
|
|
| Locked | Locked | Locked |
Hand-held device to detect bleeding in the brain
|
Detailed competitors of Bioscan Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioscan Research
Complete news archive for Bioscan Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioscan Research
Bioscan Research was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Bioscan Research is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Anupam Lavania is the current CEO of Bioscan Research. They have also founded this company.
Bioscan Research is a funded company, having raised a total of $1.03M across 5 funding rounds to date.
Annual revenue of Bioscan Research is $171.21K as on Mar 31, 2023.
Bioscan Research was established in 2013 in Ahmedabad, India, within the healthcare sector focused on medical devices and AI applications. Intracranial haemorrhage screening is facilitated through portable tools designed for use at trauma sites, supporting patient triaging and diagnostic processes. Detection of mild traumatic brain injuries is enabled, particularly for asymptomatic or mildly symptomatic cases, to aid early intervention in clinical settings.
Bioscan Research's top competitors include ClearMind Biomedical and InfraScan.
Bioscan Research offers CEREBO.
Bioscan Research has 5 investors. Key investors include Indian Institute of Technology Kanpur, Bind 4.0, iCreate, Capria, and Unicorn India Ventures.
The valuation of Bioscan Research is $1.4M as of Sep 2019.